DSIJ Mindshare

APL receives tentative USFDA approval, stock pierces its previous resistance

Bhagyashree Vivarekar 0 2741 Article rating: 5.0

Alembic Pharmaceuticals (APL) has received USFDA tentative approval for its ANDA Alogliptin tablets of 6.25 mg, 12.5 mg and 25 mg. The stock of Alembic Pharmaceuticals opened on a positive note with open and low as the same level, indicating optimism throughout the day. 

RSS
First65266527652865296531653365346535Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR